Combination Testing of Cediranib (AZD2171) against Childhood Cancer Models by the Pediatric Preclinical Testing Program

BACKGROUND: Cediranib (AZD2171) is a potent small molecule inhibitor of vascular endothelial growth factor VEGF receptors. Cediranib has demonstrated single agent activity in several adult cancers and is being studied in combination with standard cytotoxic agents in multiple disease settings. PROCED...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morton, Christopher L., Maris, John M., Keir, Stephen T., Gorlick, Richard, Kolb, E. Anders, Billups, Catherine A., Wu, Jianrong, Smith, Malcolm A., Houghton, Peter J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3253323/
https://ncbi.nlm.nih.gov/pubmed/21538824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados